Research Site

Kazımkarabekir 01230

1 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Papillary Renal Cell Carcinoma, Scleroderma, Systemic Sclerosis

Studies at this site

• A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event — Recruiting now
• Determine Effectiveness of Anifrolumab In SYstemic Sclerosis (DAISY) — Running, not enrolling
• Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC — Running, not enrolling